525: Elexacaftor/tezacaftor/ivacaftor therapy alters the CF lung mucus metabolome, reshaping microbiome niche spaceRobert A. Quinn, Douglas Conrad, Douglas V. Guzior et al.|Journal of Cystic Fibrosis|2021Cited by 1